메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Fosun Pharma Announces 2025 Interim Results

[ 메디채널 김갑성 기자 ] Enhancing Innovation Efficiency and Steadily Expanding Globally SHANGHAI, Aug. 26, 2025 -- On August 26, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company, announced its operating performance for the first half of 2025 ("the Reporting Period"). During the Reporting Period, Fosun Pharma continued to push forward its innovation transformation and the development and commercialization of innovative products, enhance glo
- 김갑성 기자
- 2025-08-26 20:42
Ping An Reports Stable Growth in Operating Profit Attributable to Shareholders of the Parent Company in 1H2025; Life & Health NBV Surges 39.8% YoY Interim Dividend Increases to RMB0.95 Per Share

HONG KONG and SHANGHAI, Aug. 26, 2025 -- Ping An Insurance (Group) Company of China, Ltd. ("Ping An", the "Company" or the "Group", HKEX: 2318; SSE: 601318) today announced its 2025 interim results for the six month period ended 30 June 2025. In 2025, leveraging Ping An's previous achievements, the Group continued to drive reform and innovation, making significant progress in both its strategic advancement and service enhancements. China's economy was generally stable and improved steadily despite pressure from a complex and severe external environment in
- 황정호 기자
- 2025-08-26 20:39
Lianlian DigiTech's H1 2025 Revenue grew 26.8%, a Record High, Net Profit Tops RMB 1.51 Billion

HANGZHOU, China, Aug. 26, 2025 -- Lianlian DigiTech Co., Ltd. (HKEX: 2598), a leader in China's digital payment solution market and global commerce digitalization, today reported interim results for the six months ended June 30, 2025. Total transaction payment volume (TPV) of the digital payment business reached RMB 2.07 trillion, a year-on-year increase of 32.0%. Global TPV reached RMB 198.5 billion, a year‑on‑year increase of 94.0%. Total revenue amounted to a record high of RMB 782.7 million, growing 26.8% year-on-year. Gross profit was RMB 406.2 million, gross profit margin
- 황정호 기자
- 2025-08-26 20:19
EquiLend Onboards EFG Hermes as First Saudi Arabia-Based Client on NGT Trading Platform

Milestone deal marks EquiLend's expansion into the Kingdom with full-suite automation adoption NEW YORK, Aug. 26, 2025 -- EquiLend today announced that EFG Hermes is going live on the firm's Next Generation Trading (NGT) platform, becoming EquiLend's first trading client based in the Kingdom of Saudi Arabia, and the first in the region to adopt full post-trade and trading automation via EquiLend. EFG Hermes, an EFG Holding company, is the leading investment bank in the Middle East and North Africa (MENA), offering an extensive array of financial services, encompassing ad
- 황정호 기자
- 2025-08-26 20:00
HEXCLAD ANNOUNCES F1 DRIVER YUKI TSUNODA AS GLOBAL AMBASSADOR

Tsunoda Joins Gordon Ramsay in High-Performance Campaign Blending Speed, Precision, Culinary Excellence LOS ANGELES, Aug. 26, 2025 -- HexClad, the performance-driven kitchenware brand beloved by top chefs and ambitious home cooks alike, today announced Yuki Tsunoda, rising Formula 1 star, as its newest Global Brand Ambassador. The partnership kicks off an international campaign that brings together the precision of racing and the artistry of cooking, two worlds where elite tools, focus, and execution make all the difference. HEXCLAD ANNOUNCES F1 DRIVER YUKI TSUNODA
- 황정호 기자
- 2025-08-26 20:00
ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA

At EURETINA 2025, ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care: IMPROVE PATHOLOGY DETECTION: Now CE mark approved, CIRRUS® PathFinderTM AI decision support tool streamlines OCT data review; ICGA for CLARUS® 700 offers FA + ICG simultaneous capture. ACCELERATE RETINA RESEARCH: AI-ready ZEISS Research Data Platform (RDP) empowers retina specialists to transform their clinical hypotheses into measurable outcomes through smarter, more efficient research. TRANSFORM VITR
- 김갑성 기자
- 2025-08-26 20:00
앤젤어라인 테크놀로지, 2025년 상반기 실적 발표… 법률•공급망•데이터 보안 투자 확대

샌클레멘테, 캘리포니아주, 2025년 8월 26일 -- 투명 교정기 전문회사인 앤젤어라인 테크놀로지(Angelalign Technology Inc., 이하 '앤젤' 또는 '회사')(6699.HK)가 2025년 상반기 견고한 반기실적을 발표했다. 상반기 매출은 전년 동기 대비 33.1% 증가한 1억 6140만 달러를 기록했고, 매출 총이익과 조정 순이익은 각각 1억 60만 달러와 1950만 달러를 달성했다. 글로벌 투명 교정기 치료 건수는 전년 동기 대비 47.7% 증가한 약 22만 5800건을 기록했다. 교정기 출하량 증가와 치료 계획 센터 및 투명 교정기 제조 시설의 효율적인 운영이 매출, 매출 총이익, 영업 이익의 전년 동기 대비 개선을 이끌었다. 보고 기간 동안 회사의 수익성은 불확실한 관세 환경을 대비해 시행한 엄격한 비용 관리 조치의 혜택을 받았다. 회사는 일부 영업•마케팅, 임상 지원 및 고객 서비스 인력 채용을 미루는 한편, 중국 본토 외 지역에서 치료 계획 센터 및 제조 시설 운영을 지연시켰다. 앤젤은 해외에서 보다 지속 가능한 존재감을 확립하기 위해 전략적으로 여러 핵심 분야
- 김갑성 기자
- 2025-08-26 19:34
Beauty Farm Announces 2025 Interim Results

Revenue and Net Profit Reached Record High Cash-generating Capability Significantly Enhanced HONG KONG, Aug. 26, 2025 -- Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or the "Company") (02373.HK), one of the largest beauty and wellness services providers in China, together with its subsidiaries, the "Group," is pleased to announce the Group's audited interim results for the six months ended June 30, 2024 (the "Reporting Period"). Performance Highlights: Revenue surged to RMB1,459 million, representing a YOY i
- 김갑성 기자
- 2025-08-26 19:05
MITTI LABS SUPPORTS THE NATURE CONSERVANCY IN ACCELERATING CLIMATE ACTION SOLUTIONS THROUGH ADVANCED TECHNOLOGY FOR SCALABLE PRACTICE SHIFTS

Cooperation will accelerate the widespread transition to Climate-smart rice farming initiatives in Northwest India using advanced satellite and AI technology BENGALURU, India, Aug. 26, 2025 -- Mitti Labs, an AI remote sensing and field operations company that empowers rice farmers with Climate-smart practices, today announced its participation in The Nature Conservancy's PRANA program ('Promoting Regenerative and No-Burn Agriculture'). PRANA is TNC's landmark initiative tackling stubble burning and soil degradation in Punjab. Since 2022, PRANA has worked across 18 districts, he
- 황정호 기자
- 2025-08-26 19:00
Brightonix Imaging's High-Performance 'PHAROS' PET Receives FDA Clearance

SEOUL, South Korea, Aug. 26, 2025 -- Brightonix Imaging, a global leader in cutting-edge medical imaging technology, is proud to announce that its flagship product, the PHAROS PET Scanner, has received FDA clearance for commercial distribution in the United States. This milestone marks a new era of precision and efficiency in nuclear imaging and positions Brightonix Imaging at the forefront of medical innovation. The PHAROS PET is a state-of-the art clinical positron emission tomography (PET) system designed to deliver exceptional image quality, offering healthcare providers a
- 김갑성 기자
- 2025-08-26 19:00

이전

41 42 43 44 45 46 47 48 49 50

많이 본 기사

최근기사

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 06일 00시 40분